Form 8-K - Current report:
SEC Accession No. 0000950170-24-130436
Filing Date
2024-11-25
Accepted
2024-11-25 08:55:23
Documents
3
Period of Report
2024-11-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hura-20241125.htm 8-K 65901
2 EX-99.1 hura-ex99_1.htm EX-99.1 66633
3 GRAPHIC img112559081_0.jpg GRAPHIC 123916
  Complete submission text file 0000950170-24-130436.txt   304716
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 241492163
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)